Bellerophon Therapeutics, Inc. (BLPH)
Chart Events
Performance Outlook
| Previous Close | 0.3751 |
| Open | 0.3752 |
| Bid | 0.3755 x 1800 |
| Ask | 0.4200 x 1300 |
| Day's Range | 0.3752 - 0.3900 |
| 52 Week Range | 0.3700 - 12.5800 |
| Volume | |
| Avg. Volume | 186,104 |
| Market Cap | 4.593M |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2400 |
| Earnings Date | Nov 13, 2023 - Nov 17, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.00 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for BLPH
Related Research
- Bellerophon Therapeutics, Inc.Daily – Vickers Top Insider Picks for 03/20/2023The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.RatingFair ValueEconomic Moat6 months agoArgus Research
ZacksBellerophon Therapeutics (BLPH) Dips More Than Broader Markets: What You Should Know
In the latest trading session, Bellerophon Therapeutics (BLPH) closed at $0.69, marking a -1.78% move from the previous day.
- Zacks
Bellerophon Therapeutics (BLPH) Stock Sinks As Market Gains: What You Should Know
Bellerophon Therapeutics (BLPH) closed the most recent trading day at $0.68, moving -1.93% from the previous trading session.
InvestorPlace7 Must-Have Stocks to Buy and Hold for a Secure Future
One reason we invest in the stock market is that we’re all looking to secure our financial futures. We want to be comfortable in our retirements and provide for our families and even future generations. Getting there means finding reliable buy and hold stocks for long-term portfolios. Warren Buffett, of course, is the acknowledged king of buy and hold stocks, or long-term investing. The Oracle of Omaha makes his fair share of trades, but his famed portfolio also includes many stocks he’s held fo
